Medtronic stock: buy or sell?

MDT stock price: $107.83 0.04% At close on August 22nd, 2019

Updated on:
August 22nd, 2019

5

After marking all time highs on Tuesday, Medtronic remained constant 0.04% yesterday to $107.83. Thursday was the 5th climbing day in a row, marking 6.02%.

Medtronic plc manufactures and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide.

Should I buy Medtronic stock?

You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

Currently, 2 buy setups match with Medtronic stock now:

Buy setupElegible
New all-time highYes
New 52 week highYes
Price crossing up 200d MANo
100d MA crossing up 200d MANo

Is Medtronic stock a buy?

Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness. At Stocks2.com, we detected 15 ratings published for MDT stock in the last 30 days.

The general sentiment of these ratings is bullish for MDT stock, with 11 positive ratings.
Is MDT a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-8-21Wells Fargo & Con/aOutperform
2019-8-21UBS Groupn/aBuy
2019-8-21Stifel Nicolausn/aHold
2019-8-21Raymond Jamesn/aBuy
2019-8-21Raymond Jamesn/aOutperform
2019-8-21Northland Securitiesn/aHold
2019-8-21Morgan Stanleyn/aEqual Weight
2019-8-21BTIG Researchn/aBuy
2019-8-21BMO Capital Marketsn/aOutperform
2019-8-21BMO Capital Marketsn/aOutperform
2019-8-21Barclaysn/aOverweight
2019-8-19Deutsche Bankn/aBuy
2019-8-16Royal Bank of Canadan/aOutperform
2019-8-14Morgan Stanleyn/aEqual Weight
2019-8-14Cowenn/aOutperform

Medtronic stock analysis

Daily outlook

After marking all time highs on Tuesday, Medtronic remained constant 0.04% to $107.83.

After topping to all time highs on Tuesday, Medtronic remained steady 0.04% to $107.83. On July, SMA100d and SMA200d crossed up triggering a rise of 11.33%. Since price and SMA200d lines crossed up on May, MDT climbed $19.56 (22.16%). From a daily perspective, MDT is in a short term uptrend after plotting its last bottom ($100.63, on Aug/15) higher than the previous bottom, and its last top ($109.70, on Tuesday) also over the previous top. Now trading in between its last bottom and last top MDT might consolidate in a plain range, waiting to break out over $109.70 or down under $100.63. On Tuesday, MDT hit a new all time high, pushing higher than on Monday tops. Check different trading setups that use ATHs as triggers.

MDT stock chart (daily)

Weekly outlook

Medtronic ended this week at $107.83 after reaching a new all time high ($109.70) and climbed a cool 4.93%.

MDT shows a strong mid-term uptrend with several rising tops and rising bottoms. Since its last bottom early August, MDT climbed unceasignly breaking out to new all time highs. Since SMA20d and SMA40w crossed up late June, MDT price climbed $8.99 per share (9.10%). Since price and SMA40w lines crossed up late May, MDT climbed $20.58 (23.59%).

MDT stock chart (weekly)

Medtronic stock price history

Medtronic stock historical price chart

MDT stock reached all-time highs on Tuesday with a price of $109.70.

Medtronic stock price target is $114.10

Nobody can reliably foresee how stock prices may evolve in the future. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. We have 15 price predictions for MDT stock published in the last 30 days:
MDT stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-8-21Wells Fargo & CoReiterates$110.00$120.009.1%
2019-8-21UBS GroupRaises Target$112.00$122.008.9%
2019-8-21Stifel NicolausReiterates$95.00$112.0017.9%
2019-8-21Raymond JamesReiterates$105.00$118.0012.4%
2019-8-21Raymond JamesRaises Target$105.00$118.0012.4%
2019-8-21Northland SecuritiesReiteratesn/a$100.00-
2019-8-21Morgan StanleyRaises Target$105.00$111.005.7%
2019-8-21BTIG ResearchRaises Targetn/a$120.00-
2019-8-21BMO Capital MarketsReiterates$107.00$118.0010.3%
2019-8-21BMO Capital MarketsRaises Target$107.00$118.0010.3%
2019-8-21BarclaysRaises Target$110.00$117.006.4%
2019-8-19Deutsche BankReiterates$100.00$111.0011%
2019-8-16Royal Bank of CanadaRaises Targetn/a$110.00-
2019-8-14Morgan StanleyRaises Target$100.00$105.005%
2019-8-14CowenReiterates$99.00$111.0012.1%
(in average)$104.60$114.109.0%
The price prediction for Medtronic stock is $114.10, moving in a range between $122.00 and $100.00. In average, analysts' outlook on MDT price target is positive, improving the target by a 9.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

Medtronic presented slightly good results for 2019-Q1 on February. Medtronic appreciated Earnings per Share (EPS) by 4.00%, beating analysts consensus of $1.24. Medtronic posted $1.29.
MDT earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q2-n/an/an/a
2017-Q3-n/an/an/a
2017-Q4-n/an/an/a
2018-Q12018-02-201.161.170.9%
2018-Q22018-05-241.381.422.9%
2018-Q32018-08-211.111.175.4%
2018-Q42018-11-201.141.227.0%
2019-Q12019-02-191.241.294.0%
2019-Q2-n/an/an/a
2019-Q3-n/an/an/a

Annual financial results

In 2018, Medtronic annual sales remained steady a tight 0.01% to $29,953.00 million USD from $29,950.00 marked in 2018. When comparing 2018 vs 2018, aligned with this, profit margin (that is, the net income divided by revenues) stayed stable a 0.01% to 10.36%.

To have an updated view of the financial situation of Medtronic, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2019-Q1 that can be compared to 2018 fiscal year results. Annual Medtronic TTM sales up to January 2019 were $30,555.00 and earnings were $4,919.00 M USD. If we compare this TTM figures with the last reported annuality, we can review Medtronic business evolution since April 2018: Annual sales up to January, compared to lastest yearly report, grew a slightly good 2.01%. Regarding profit margin, Medtronic soared 5.74% to 10.36%

MDT annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2014$17,010 M-$3,070 M18.0%-
2014$17,010 M0.00%$3,070 M18.0%0.00%
2015$20,260 M19.11%$2,680 M13.2%-12.70%
2015$20,261 M0.00%$2,675 M13.2%-0.19%
2016$28,830 M42.29%$3,540 M12.3%32.34%
2016$28,833 M0.01%$3,538 M12.3%-0.06%
2017$29,710 M3.04%$4,030 M13.6%13.91%
2017$29,710 M0.00%$4,028 M13.6%-0.05%
2018$29,950 M0.81%$3,100 M10.4%-23.04%
2018$29,953 M0.01%$3,104 M10.4%0.13%
TTM $30,555 M2.01%$4,919 M16.1%58.47%

Quarterly financial results

Medtronic reported $7,546.00 million in revenues for 2019-Q1, a 0.87% improvement compared to previous quarter. Reported quarter earnings marked $1,269.00 million with a profit margin of 16.82%. Profit margin inched a 1.91% compared to previous quarter when profit margin was 14.90%. When comparing revenues to same quarter last year, Medtronic sales marked a tiny growth and stepped up a 2.40%. Looking back to recent quarterly results, Medtronic posted 2 positive quarters in a row.
MDT quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q2$7,920 M-$1,160 M14.6%-
2017-Q3$7,390 M-6.69%$1,020 M13.8%-12.07%
2017-Q4$7,050 M-4.60%$2,017 M28.6%97.75%
2018-Q1$7,369 M4.52%$-1,389 M-18.8%-168.86%
2018-Q2$8,144 M10.52%$1,460 M17.9%-205.11%
2018-Q3$7,384 M-9.33%$1,075 M14.6%-26.37%
2018-Q4$7,481 M1.31%$1,115 M14.9%3.72%
2019-Q1$7,546 M0.87%$1,269 M16.8%13.81%

Medtronic ownership

When you are planning to invest in a stock, it's worth to overview its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Medtronic, 0.06% of all outstanding shares are owned by its staff.

Bearish positions for MDT stock account 0.00%, no big difference from last month.

For a better context understanding, the next table shows ownership data compared to other related stocks:

MDTABTBAXBSXCNMD
Market cap$0.0 M$148.5 B$44.5 B$59.3 B$2.9 B
Total shares0.0 M1,760.0 M510.2 M1,390.0 M28.3 M
Float shares1,340.0 M1,750.0 M509.5 M1,390.0 M27.6 M
  - Institutional holdings (%)84.2%76.5%88.2%93.4%97.5%
  - Insider holdings (%)0.1%0.7%0.1%0.2%1.8%
Shares in short selling0.0%0.0%0.0%0.0%0.0%

Medtronic summary

Thursday, August 22nd, 2019
Open$108.00
Close$107.83
Day range$107.23 - $108.31
Previous close$107.79
Session gain0.04%
Average true range$2.07
50d mov avg$100.51
100d mov avg$94.84
200d mov avg$92.27
Daily patternlt06a
Weekly pattern lb03c

Medtronic performance

To measure stock performance is always good to benchmark with competitors or related stocks. We chose , Baxter International, Boston Scientific, CONMED, Edwards Lifesciences, Integra LifeSciences, , Owens & Minor, Stryker and Zimmer Biomet as the bechmarking frame for Medtronic stock.
Stock3m6m12m
MDTMedtronic16.55%16.26%15.33%
ABT10.01%11.69%29.78%
BAXBaxter Internatio...16.45%17.41%21.84%
BSXBoston Scientific10.92%5.31%22.90%
CNMDCONMED24.26%33.89%31.07%
EWEdwards Lifescien...27.92%25.60%52.88%
IARTIntegra LifeScien...25.65%12.10%3.88%
JNJ-5.46%-2.60%-0.86%
OMIOwens & Minor38.51%-24.33%-70.27%
SYKStryker18.84%16.69%30.31%
ZBHZimmer Biomet19.98%10.63%10.23%

Medtronic competitors

We selected a few stocks to conform a list of Medtronic competitors to check if you are interested in investing in MDT:

Latest Medtronic stock news